Response Biomedical taps Shuster Capital CEO for board chairman
Response Biomedical Corp has appointed Lewis J. Shuster as chairman of its board of directors. Outgoing chairman Dr. Peter A Thompson will remain on the board. Shuster is CEO of U.S. angel investor and strategic advisory firm Shuster Capital. Headquartered in Vancouver, Response Biomedical is a maker of on-site diagnostic tests. Update: The company is a portfolio investment of U.S. life sciences-focused venture capital firm Orbimed Advisors, 3M Co and other investors.
29 August 2014•3 mins read
